This inventor holds 1 USPTO granted patent. Top assignee: Genesen Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Eun Ji Yeo: Innovator in Protein Transduction
Introduction
Eun Ji Yeo is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of protein transduction domains. Her innovative work has the potential to enhance the delivery of therapeutic agents into living cells.
Latest Patents
Eun Ji Yeo holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention proposes a more efficient protein transduction domain and fusion compound. The research led to the discovery of a GK1 peptide comprising 18 amino acids, which can bond with high-molecular-weight materials such as proteins. This bonding allows these materials to penetrate living bodies, including cells, tissues, or blood, effectively. The fusion compound, oligonucleotide, or vector derived from this research can be utilized as a pharmaceutical composition for preventing or treating diseases.
Career Highlights
Eun Ji Yeo's career is marked by her dedication to advancing biopharmaceutical technologies. Her innovative approach to protein transduction has positioned her as a key figure in her field. She works at Genesen Co., Ltd., where she continues to explore new avenues for medical applications of her research.
Collaborations
Eun Ji Yeo collaborates with talented colleagues, including Soo-Young Choi and Jin-Seu Park. Their combined expertise enhances the research and development efforts at Genesen Co., Ltd.
Conclusion
Eun Ji Yeo's contributions to the field of biotechnology through her innovative patents and collaborative efforts highlight her role as a leading inventor. Her work promises to impact the future of medical treatments significantly.